Bradley Warady
Pediatric Nephrology · Kansas City, MONPI 1114977378
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $41,923 of the $61,084 with a category attached, or 68.6%. 16 manufacturers reported payments, led by GSK at 31.3% of the total. Reporting peaked in 2022 at $16,166 and has fallen 61.4% since, to $6,245 in 2025. Among pediatric nephrology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $939.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$19K
- Bayer$15K
- Amgen$6K
- Akebia Therapeutics Inc$5K
- AMAG Pharmaceuticals, Inc.$4K
- Vifor Pharma, Inc.$4K
- plus $9K from 10 others
Across 107 payments — averaging $6260.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$267K
- Leadiant Biosciences, Inc.$147K
- Bayer$108K
- Genentech, Inc.$78K
- Akebia Therapeutics Inc$28K
- Rockwell Medical, Inc.$13K
- plus $29K from 6 others
What the payments were for
- Consulting fees$41,92369%
- Speaking & faculty fees$13,67922%
- Travel & lodging$4,1157%
- Food & beverage$1,3682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 6 | $19,089 |
| Bayer | 28 | $14,660 |
| Amgen(2 entities) | 13 | $6,394 |
| Akebia Therapeutics Inc | 1 | $4,736 |
| AMAG Pharmaceuticals, Inc. | 2 | $3,750 |
| Vifor Pharma, Inc. | 3 | $3,708 |
| F. Hoffmann-la Roche AG | 2 | $3,204 |
| Leadiant Biosciences, Inc. | 1 | $2,000 |
| Gilead | 1 | $2,000 |
| AstraZeneca | 1 | $1,150 |
| Hoffmann-la Roche Limited | 2 | $171 |
| Ultragenyx Pharmaceutical Inc. | 1 | $84 |
| Alnylam Pharmaceuticals Inc. | 1 | $43 |
| Mallinckrodt Enterprises LLC | 1 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $33 |
| Vifor (international) Ltd. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,084 in reported general payments places this provider in the 95th percentile of 26 pediatric nephrology providers in Missouri.
Other pediatric nephrology in Kansas City
- Tarak SrivastavaKansas City$28K
- Uri AlonKansas City$22K
- Judith VansickleKansas City$18K
- Laurel WilligKansas City$17K
- Vimal ChadhaKansas City$2K
- Heather MorgansKansas City$2K
- Donna ClaesKansas City$1K
- Darcy WeidemannKansas City$259
- Naile Tufan PekkucuksenKansas City$48
- Nathan BeinsKansas City$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.